Last reviewed · How we verify

Analgesia at home

Universidade do Porto · FDA-approved active Small molecule Quality 5/100

Analgesia at home is a Small molecule drug developed by Universidade do Porto. It is currently FDA-approved.

At a glance

Generic nameAnalgesia at home
SponsorUniversidade do Porto
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Analgesia at home

What is Analgesia at home?

Analgesia at home is a Small molecule drug developed by Universidade do Porto.

Who makes Analgesia at home?

Analgesia at home is developed and marketed by Universidade do Porto (see full Universidade do Porto pipeline at /company/universidade-do-porto).

What development phase is Analgesia at home in?

Analgesia at home is FDA-approved (marketed).

Related